Improvement in the dissolution of poorly water soluble drug using media milling technique

Thai Journal of Pharmaceutical Sciences

Volumn 34, Issue 4, 2010, Pages 155-164

  Patel, Dhaval J ^a   Patel, Jayvadan K ^b   Pandya, Vikram M ^a  

^a Shree Krishna Institute of Pharmacy   (India)

^b Nootan Pharmacy College   (India)

Author keywords

Drug to stabilizer ratio; Famotidine; Media milling; Nanosuspension; Zirconium beads

Indexed keywords

FAMOTIDINE; NANOPARTICLE; ZIRCONIUM OXIDE;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSPENSION;

EID: 78751530219     PISSN: 01254685     EISSN: 19054637     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. P. Sharma, W.A. Denny, and S. Garg. Effect of wet milling process on the solid state of indomethacin and simvastatin, Int. J. Pharm. 380: 40-48 (2009).
2. M. Kakrana, N. G. Sahooa, L. Lia, Z. Judeh, Y. Wang, K. Chong, and L. Loh. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension, Int. J. Pharm. 383: 285-292 (2010).
3. S. Verma, R. Gokhale, and D. J. Burgessa. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int. J. Pharm. 380: 216-222 (2009).
4. F. Lai, C. Sinico, G. Ennas, F. Marongiu, G. Marongiu, and A.M. Fadda. Diclofenac nanosuspensions: Influence of preparation procedure and crystal form on drug dissolution behavior, Int. J. Pharm. 373: 124-132 (2009).
5. S. Vermaa, Y. Lan, R. Gokhale, and D. J. Burgessa. Quality by design approach to understand the process of nanosuspension preparation, Int. J. Pharm. 377: 185-198 (2009).
6. V. E. Eerdenbruch, J. Vermant, J. A. Martens, L. Froyen, J. V. Humbeeck, A. Augustins, and G. Mooter. A screening study of surface stabilization during the production of drug nanocrystals, J. Pharm. Sci. 98: 2091-2103 (2008).
7. M. A. Hassan, M. S. Suleiman, and N. M. Najib. Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin, Int. J. Pharm. 58: 19-24 (1990).
8. H. F. Rania, and A. K. Mohammed. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: In vitro and in vivo evaluation, Eur. J. Pharm. Biopharm. 69: 993-1003 (2008).
9. A. Dolenc, K. Julijana, S. Baumgartner, and O. Planinsek. Advantages of celecoxib nanosuspension formulation and transformation into tablets, Int. J. Pharm. 376: 204-212 (2009).
10. C. Reppas, and E. Nicolaides. Analysis of drug dissolution data. In: J. B. Dressman, and H. Lennernas. Oral Drug Absorption Prediction and Assessment (eds.), Marcel Dekker, New York, 2000, pp. 229-254.
11. M. L. Vueba, L. A. E. Batista de carvalho, F. Veiga, J. J. Sous, and M. E. Pina. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets, Eur. J. Pharm. Biopharm. 58: 51-59 (2004).